Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

METOPROLOL BASE

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

62 API Suppliers, 29 USDMF, 16 CEP/COS, 3 JDMF, 11 EU WC, 14 NDC API, 27 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

63 Drugs in Development

63 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

448 FDF Dossiers, 85 FDA Orange Book, 227 Europe, 35 Canada, 28 Australia, 1 South Africa, 72 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG, TABLET;ORAL - 50MG, INJECTABLE;INJECTION - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 5 DKSH, 5 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 5 Kirsch Pharma, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 28 BASF, 1 Clariant, 10 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 2 Finar, 10 Gangwal Chemicals, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 20 Roquette, 15 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

54 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 30 Granulation, 30 Direct Compression, 29 Thickeners and Stabilizers, 29 Solubilizers, 27 Disintegrants & Superdisintegrants, 23 Controlled & Modified Release, 20 Topical, 20 Lubricants & Glidants, 19 Parenteral, 16 Film Formers & Plasticizers, 13 Co-Processed Excipients, 10 Emulsifying Agents, 10 Taste Masking, 8 Chewable & Orodispersible Aids, 8 Surfactant & Foaming Agents, 7 Rheology Modifiers, 6 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents

DIGITAL CONTENT

24 News #PharmaBuzz

24 News #PharmaBuzz

GLOBAL SALES INFORMATION

22 US Medicaid Prescriptions, 75 Regulatory FDF Prices, 5 Annual Reports

MARKET PLACE

16 APIs, 11 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 25 Others

ANALYTICAL

2 BioAnalytical Methods, 4 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Moehs Iberica	Spain	Moehs Iberica S.L. Rubi ES	CEP 1996-021 - Rev 08	Metoprolol tartrate	2024-02-28	Valid	Chemical		1028
29/11/2025	Actavis Inc	Ireland	WATSON PHARMA PRIVATE LIMITED Mumbai IN	R1-CEP 1999-148 - Rev 05	Metoprolol tartrate	2012-07-24	Withdrawn by Holder	Chemical	2017-10-30	1028

METOPROLOL BASE

METOPROLOL BASE

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

62 API Suppliers

29 USDMF

16 CEP/COS

3 JDMF

11 EU WC

14 NDC API

27 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

63 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

448 FDF Dossiers

85 FDA Orange Book

227 Europe

35 Canada

28 Australia

1 South Africa

72 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG

TABLET;ORAL - 50MG

INJECTABLE;INJECTION - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma

5 DKSH

5 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

1 Pfanstiehl

5 Kirsch Pharma

1 ACG Worldwide

8 Actylis

1 Aeon Procare

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

28 BASF

1 Clariant

10 Corel Pharma Chem

7 DFE Pharma

1 Esteem Industries

2 Finar

10 Gangwal Chemicals

4 Ideal Cures

4 Ingredion Pharma Solutions

24 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

3 Pharmatrans-Sanaq

6 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

20 Roquette

15 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

11 Sigachi Industries

4 Silverline Chemicals

2 The Dow Chemical Company

1 Ulanqab Kema New Material

1 Valens Pharmachem

4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

54 Fillers, Diluents & Binders

46 Coating Systems & Additives

INJECTABLE;INJECTION - 1MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons